Literature DB >> 22925337

Vironome of Kaposi sarcoma associated herpesvirus-inflammatory cytokine syndrome in an AIDS patient reveals co-infection of human herpesvirus 8 and human herpesvirus 6A.

Kristen M Tamburro1, Dongmei Yang, Jessica Poisson, Yuri Fedoriw, Debasmita Roy, Amy Lucas, Sang-Hoon Sin, Nadia Malouf, Vincent Moylan, Blossom Damania, Stephan Moll, Charles van der Horst, Dirk P Dittmer.   

Abstract

KSHV inflammatory cytokine syndrome (KICS) is a newly described condition characterized by systemic illness as a result of systemic, lytic KSHV infection. We used Illumina sequencing to establish the DNA vironome of blood from such a patient. It identified concurrent high-level viremia of human herpesvirus (HHV) 8 and 6a. The HHV8 plasma viral load was 5,300,000 copies/ml, which is the highest reported to date; this despite less than five skin lesions and no HHV8 associated lymphoma. This is the first report of systemic HHV6a/KSHV co-infection in a patient. It is the first whole genome KSHV sequence to be determined directly from patient plasma rather than cultured or biopsied tumor material. This case supports KICS as a new clinical entity associated with KSHV.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22925337      PMCID: PMC3505605          DOI: 10.1016/j.virol.2012.08.014

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  27 in total

1.  Human herpesvirus 8 load in matched serum and plasma samples of patients with AIDS-associated Kaposi's sarcoma.

Authors:  Abeltje M Polstra; Remco Van Den Burg; Jaap Goudsmit; Marion Cornelissen
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

2.  Profiling of pre-micro RNAs and microRNAs using quantitative real-time PCR (qPCR) arrays.

Authors:  Pauline Chugh; Kristen Tamburro; Dirk P Dittmer
Journal:  J Vis Exp       Date:  2010-12-03       Impact factor: 1.355

3.  Identification of human herpesvirus 6 variants A and B by primer-specific real-time PCR may help to revisit their respective role in pathology.

Authors:  David Boutolleau; Caroline Duros; Pascale Bonnafous; Delphine Caïola; Alexandre Karras; Nathalie De Castro; Marie Ouachée; Philippe Narcy; Marie Gueudin; Henri Agut; Agnès Gautheret-Dejean
Journal:  J Clin Virol       Date:  2005-09-23       Impact factor: 3.168

4.  High levels of human herpesvirus 8 viral load, human interleukin-6, interleukin-10, and C reactive protein correlate with exacerbation of multicentric castleman disease in HIV-infected patients.

Authors:  E Oksenhendler; G Carcelain; Y Aoki; E Boulanger; A Maillard; J P Clauvel; F Agbalika
Journal:  Blood       Date:  2000-09-15       Impact factor: 22.113

5.  Detection of murine leukemia virus in the Epstein-Barr virus-positive human B-cell line JY, using a computational RNA-Seq-based exogenous agent detection pipeline, PARSES.

Authors:  Zhen Lin; Adriane Puetter; Joseph Coco; Guorong Xu; Michael J Strong; Xia Wang; Claire Fewell; Melody Baddoo; Christopher Taylor; Erik K Flemington
Journal:  J Virol       Date:  2012-01-11       Impact factor: 5.103

6.  Human herpesvirus 6 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirus.

Authors:  Chun Lu; Yi Zeng; Zan Huang; Li Huang; Chao Qian; Guixia Tang; Di Qin
Journal:  Am J Pathol       Date:  2005-01       Impact factor: 4.307

7.  Can plasma HHV8 viral load be used to differentiate multicentric Castleman disease from Kaposi sarcoma?

Authors:  R Sayer; J Paul; P W Tuke; S Hargreaves; M Noursadeghi; R S Tedder; P Grant; S G Edwards; R F Miller
Journal:  Int J STD AIDS       Date:  2011-10       Impact factor: 1.359

8.  Immunophenotypic analysis of the Kaposi sarcoma herpesvirus (KSHV; HHV-8)-infected B cells in HIV+ multicentric Castleman disease (MCD).

Authors:  A Chadburn; E M Hyjek; W Tam; Y Liu; T Rengifo; E Cesarman; D M Knowles
Journal:  Histopathology       Date:  2008-11       Impact factor: 5.087

9.  Plasma HHV-8 viral load in HHV-8-related lymphoproliferative disorders associated with HIV infection.

Authors:  C Simonelli; R Tedeschi; A Gloghini; R Talamini; M T Bortolin; M Berretta; M Spina; S Morassut; E Vaccher; P De Paoli; A Carbone; U Tirelli
Journal:  J Med Virol       Date:  2009-05       Impact factor: 2.327

10.  Human herpesvirus 8 presence and viral load are associated with the progression of AIDS-associated Kaposi's sarcoma.

Authors:  A Scott Laney; Michael J Cannon; Harold W Jaffe; Margaret K Offermann; Chin-Yih Ou; Kay W Radford; Mitesh M Patel; Thomas J Spira; Clifford J Gunthel; Philip E Pellett; Sheila C Dollard
Journal:  AIDS       Date:  2007-07-31       Impact factor: 4.177

View more
  22 in total

1.  Whole-Genome Sequencing of Kaposi's Sarcoma-Associated Herpesvirus from Zambian Kaposi's Sarcoma Biopsy Specimens Reveals Unique Viral Diversity.

Authors:  Landon N Olp; Adrien Jeanniard; Clemence Marimo; John T West; Charles Wood
Journal:  J Virol       Date:  2015-09-30       Impact factor: 5.103

Review 2.  Kaposi sarcoma-associated herpesvirus: immunobiology, oncogenesis, and therapy.

Authors:  Dirk P Dittmer; Blossom Damania
Journal:  J Clin Invest       Date:  2016-09-01       Impact factor: 14.808

Review 3.  HIV-associated Kaposi sarcoma and related diseases.

Authors:  Priscila H Gonçalves; Thomas S Uldrick; Robert Yarchoan
Journal:  AIDS       Date:  2017-09-10       Impact factor: 4.177

4.  Kaposi's Sarcoma-Associated Herpesvirus Latency Locus Compensates for Interleukin-6 in Initial B Cell Activation.

Authors:  Sang-Hoon Sin; Sun Ah Kang; Yongbaek Kim; Anthony Eason; Kelly Tan; Hyowon An; Dirk P Dittmer
Journal:  J Virol       Date:  2015-12-09       Impact factor: 5.103

5.  Clinical Features and Outcomes of Patients With Symptomatic Kaposi Sarcoma Herpesvirus (KSHV)-associated Inflammation: Prospective Characterization of KSHV Inflammatory Cytokine Syndrome (KICS).

Authors:  Mark N Polizzotto; Thomas S Uldrick; Kathleen M Wyvill; Karen Aleman; Vickie Marshall; Victoria Wang; Denise Whitby; Stefania Pittaluga; Elaine S Jaffe; Corina Millo; Giovanna Tosato; Richard F Little; Seth M Steinberg; Irini Sereti; Robert Yarchoan
Journal:  Clin Infect Dis       Date:  2015-12-12       Impact factor: 9.079

6.  Humanized-BLT mouse model of Kaposi's sarcoma-associated herpesvirus infection.

Authors:  Lin-Xu Wang; Guobin Kang; Pankaj Kumar; Wuxun Lu; Yue Li; You Zhou; Qingsheng Li; Charles Wood
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-10       Impact factor: 11.205

7.  The open chromatin landscape of Kaposi's sarcoma-associated herpesvirus.

Authors:  Isaac B Hilton; Jeremy M Simon; Jason D Lieb; Ian J Davis; Blossom Damania; Dirk P Dittmer
Journal:  J Virol       Date:  2013-08-28       Impact factor: 5.103

Review 8.  Kaposi sarcoma associated herpesvirus pathogenesis (KSHV)--an update.

Authors:  Dirk P Dittmer; Blossom Damania
Journal:  Curr Opin Virol       Date:  2013-06-13       Impact factor: 7.090

Review 9.  KSHV: pathways to tumorigenesis and persistent infection.

Authors:  Louise Giffin; Blossom Damania
Journal:  Adv Virus Res       Date:  2014       Impact factor: 9.937

10.  Runaway Kaposi Sarcoma-associated herpesvirus replication correlates with systemic IL-10 levels.

Authors:  Carolina Caro-Vegas; Subhashini Sellers; Kurtis M Host; Jedediah Seltzer; Justin Landis; William A Fischer; Blossom Damania; Dirk P Dittmer
Journal:  Virology       Date:  2019-10-02       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.